Dosage form:
an alcoholic solution for oral, topical and external use
Registration number:
LP-005101
INN:
Eucalyptus leaf extract
Composition:
The active component:
Chlorophyllipt extract thick, - 10 mg
in terms of dry matter
Auxiliary substance:
Ethyl alcohol (ethanol) 96% - up to 1 ml
Pharmacological properties:
Pharmacodynamics
Chlorophyllipt® is a mixture of chlorophylls obtained from eucalyptus leaves. The drug has antibacterial (bacteriostatic and bactericidal) effects, especially against staphylococci, including antibiotic-resistant strains. It has an anti-inflammatory effect.
Pharmacokinetics
Not studied.
Manufacturer:
Kirov Pharmaceutical Factory JSC
Russia, 610000, Kirov, Moskovskaya str., 27a
Tel./fax (8332) 65-46-64, 65-35-10
Russia
Indications:
In the complex therapy of infectious and inflammatory diseases caused by staphylococci, including antibiotic-resistant strains; burns, long-lasting wounds and trophic ulcers of the extremities; cervical erosion; for the prevention of postoperative complications, as well as for intestinal sanitation in cases of staphylococcal carrier.
Contraindications:
• Hypersensitivity to eucalyptus leaf extract or any of the excipients.
• When ingested – age under 18 years, pregnancy, breastfeeding, liver disease, traumatic brain injury, alcoholism, brain diseases.
Method of application:
For adults, the drug is prescribed orally, topically, externally. For children under 18 years of age, the drug is prescribed topically and topically.
Inside. When used in adults with intestinal carrier of staphylococcus, 5 ml of 1% alcohol solution diluted with 30 ml of water, 3 times a day for 40 minutes before meals daily for 2-3 weeks.
Locally. In case of intestinal carriage of staphylococcus, Chlorophyllipt® is also prescribed rectally in an enema (20 ml of 1% alcohol solution is diluted in 1 liter of water - this is the dose for one enema). An enema with the drug is given every two days. For children in the volume (in ml) corresponding to their age. The course of treatment consists of 10 procedures.
In the treatment of cervical erosion, all folds of the vaginal mucosa and the vaginal part of the cervix are pre-dried with a swab and the cervical canal and erosion are lubricated with 1% alcohol solution of Chlorophyllipt® diluted 1:10. The manipulation is performed for 10 days daily, after which the patient should be syringed with a solution of the drug (1 tablespoon of 1% alcohol solution per 1 liter of water). The course of treatment is 2 weeks. In case of incomplete epithelialization, the course of treatment is repeated.
Externally, in the treatment of burns, long-term non-healing wounds and trophic ulcers, a 1% alcohol solution of Chlorophyllipt is diluted with a 0.25% solution of novocaine in a ratio of 1:5 and used as gauze dressings soaked in this solution. The course of treatment is 2-3 weeks.
If there is no improvement after treatment, or the symptoms worsen, or new symptoms appear, it is necessary to consult a doctor. Use the drug only according to the indications, the method of use and in the doses specified in the instructions.
Use during pregnancy and lactation:
During pregnancy and lactation, oral administration is contraindicated. External and topical application is possible if the expected benefit to the mother exceeds the potential risk to the fetus and child. It is necessary to consult a doctor.
Side effect:
Allergic reactions (swelling of lips, mucous membranes, skin rashes).
If you experience side effects listed in the instructions or they worsen, or you notice any other side effects not listed in the instructions, tell your doctor.
Overdose:
To date, there have been no cases of overdose with the correct use of the drug.
Interaction with other medicinal products:
Interactions with other drugs are unknown.
Special instructions:
It is not recommended to apply the drug to large areas of the skin, as phenol, which is part of the drug, can enter the bloodstream and cause toxic effects (dizziness, weakness).
The drug has a peculiar smell and red color and can stain laundry.
Influence on the ability to drive vehicles, mechanisms :
Form of release:
A solution for external use.
10, 25 ml of the drug into orange glass vials capped with polyethylene stoppers or dropper stoppers, with polymer caps screwed on or screwed on with the control of the first opening, or caps with an applicator for application, it is also allowed to use caps, or caps with an applicator, or dropper caps without a stopper.
It is allowed to attach an applicator to the pack for applying the drug.
A paper label or self-adhesive label is applied to the vials.
Each vial, along with the instructions for medical use, is placed in a cardboard pack.
It is allowed to apply the text of the instructions for medical use on a cardboard pack.
By 10, 16, 20, 30, 40, 56, 112 10, 25 ml vials with the appropriate number of instructions for medical use are placed in a cardboard box or a corrugated cardboard box (for hospitals).
1; 4.5; 10; 18 kg (for pharmacy production departments) in glass bottles.
A paper label or self-adhesive label is applied to the bottles.
Storage and transportation conditions:
In a place protected from light at a temperature of 8 to 25 ° C.
Keep out of reach of children.
